Top Markets
#1 Fake World Assets Fake World Assets +10.69%
#2 B3 (Base) B3 (Base) +10.34%
#3 Janction Janction +9.46%
#4 Verus Coin Verus Coin +7.95%
#5 TENDIES TENDIES +6.38%
#6 GoPlus Security GoPlus Security +4.67%
#7 龙虾 (Lobster) 龙虾 (Lobster) +4.03%
#8 Provenance Blockchain Provenance Blockchain +3.76%
#9 Everything Everything +3.72%
#10 OVERTAKE OVERTAKE +3.30%
Coin of the day
Fake World Assets Fake World Assets
설정
언어
한국어
통화
USD
테마
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
주식 순위 #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
주가
$0.617
마지막 동기화: 2024-10-14
시가총액
$6.13M
변동 (1일)
0.49%
변동 (1년)
0.00%
국가
US
거래 Kineta, Inc. (KA)

카테고리

Healthcare
Kineta, Inc. (KA)의 EPS
March 2025 기준 EPS TTM: $-0.66
Kineta, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-0.66입니다. 2023년 말에는 회사의 EPS가 $-1.28였으며, 이는 2022년의 EPS $-12.80와 감소입니다.
Kineta, Inc.의 EPS 기록 (2015 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-0.66 -53.52%
2024 $-1.42 10.94%
2023 $-1.28 -90.00%
2022 $-12.80 57.25%
2021 $-8.14 -80.27%
2020 $-41.26 -74.51%
2019 $-161.86 -28.02%
2018 $-224.87 -31.33%
2017 $-327.48 17.86%
2016 $-277.86 97.27%
2015 $-140.85 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,724.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -4,303.03%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -2,175.77%
BE